A Phase 1, Randomized, Open-label, Crossover Study to Evaluate the Effect of the Organic Anion Transporter Inhibitor Probenecid on the Pharmacokinetics of JNJ-64041575 in Healthy Adult Subjects

Trial Profile

A Phase 1, Randomized, Open-label, Crossover Study to Evaluate the Effect of the Organic Anion Transporter Inhibitor Probenecid on the Pharmacokinetics of JNJ-64041575 in Healthy Adult Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Aug 2017

At a glance

  • Drugs Lumicitabine (Primary) ; Probenecid
  • Indications Metapneumovirus infections; Parainfluenza virus infections; Respiratory syncytial virus infections
  • Focus Pharmacokinetics
  • Sponsors Janssen-Cilag
  • Most Recent Events

    • 24 Jul 2017 Status changed from recruiting to completed.
    • 12 May 2017 Planned End Date changed from 6 Dec 2017 to 12 Jun 2017.
    • 14 Apr 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top